Pathogenic variants in retinoblastoma suggest a potential gain-of-function mutation
“In other words, the pR552* mutant behaves more like a gain-of-function or oncogenic mutant. Indeed, a family carrying this mutation showed complete penetrance and high expressivity”
2025-01-29
(Press-News.org)
“In other words, the pR552* mutant behaves more like a gain-of-function or oncogenic mutant. Indeed, a family carrying this mutation showed complete penetrance and high expressivity.”
BUFFALO, NY- January 29, 2025 – A new research paper was published in Volume 16 of Genes & Cancer on January 20, 2025, entitled, “Analysis of pathogenic variants in retinoblastoma reveals a potential gain of function mutation.”
Researchers from Instituto de Física Universidad Autónoma de San Luis Potosí and Hospital Central “Ignacio Morones Prieto” have found a new way a gene mutation might contribute to retinoblastoma, a type of eye cancer that affects young children. The study suggests that a specific genetic change, pR552*, may not only stop the gene from working properly but could also give it a new function that leads to cancer growth. This challenges the common belief that both copies of the retinoblastoma gene (RB1) must be damaged for cancer to develop.
Retinoblastoma is the most common eye cancer in children under five years old. It happens when RB1, which usually helps control cell growth, stops functioning correctly. When this happens, cells can grow uncontrollably and form tumors in the eye. Early signs include the appearance of a white glow in the pupil, misaligned eyes, or vision problems, and prompt detection and treatment can significantly improve outcomes for children.
In this study, the scientists, using in vitro human cell models, examined three specific changes in the RB1 gene. They found that one of them, pR552*, made cells grow, survive, and move more than usual. Unlike other mutations, this one seemed to have an additional harmful effect, even when only one copy of the gene was affected.
The researchers also studied a family in Mexico where the pR552* mutation was passed down from the father to all three of his children, each of whom developed retinoblastoma. This suggests that the mutation might be more powerful than previously thought, possibly causing cancer even if the second copy of the gene is normal.
This discovery could change the way clinicians understand and treat retinoblastoma. Until now, it was believed that both copies of the RB1 gene needed to be damaged for the disease to appear. But this study suggests that just one faulty copy of the gene might be enough to start the disease. If confirmed, these findings could support the development of genetic screening tools to identify at-risk children earlier and inform personalized treatment strategies.
“This mutant pR552* has been identified with high recurrence in different studies in Vietnamese, Portuguese, Canadian, American, English, and Mexican (this work) patients among others; consequently, we decided to continue studying this particular mutant.”
The researchers plan to continue studying this mutation to better understand how it works and whether it also plays a role in other cancers, such as bone and brain tumors. Their work could lead to new approaches for fighting retinoblastoma and possibly other cancers linked to the RB1 gene.
Continue reading: DOI: https://doi.org/10.18632/genesandcancer.239
Correspondence to: Vanesa Olivares-Illana - vanesa@ifisica.uaslp.mx, and Jesús Hernández-Monge - jesus_hernandez_m@hotmail.com
Keywords: cancer, retinoblastoma, gain of function, mutants, pathogenic variants
Click here to sign up for free Altmetric alerts about this article.
About Genes & Cancer:
Genes & Cancer covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, their role in signal transduction and the mechanisms by which their expression and function are altered during tumor development. In addition to publishing manuscripts that directly relate to these areas of research, Genes & Cancer also aims to attract papers in the areas of genomics, drug development and systems biology.
To learn more about Genes & Cancer, visit www.genesandcancer.com and connect with us on social media:
X
Facebook
YouTube
LinkedIn
Instagram
For media inquiries, please contact media@impactjournals.com.
Genes & Cancer Journal Office
6666 East Quaker St., Suite 1
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 3)
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2025-01-29
The American Association for the Advancement of Science (AAAS), the nonprofit publisher of the Science family of journals, is conducting a pilot with ProRata as part of its commitment to communicate trusted scientific findings broadly. ProRata is an AI company guided by the belief that content creators should receive attribution for their work. Partnering with AAAS will strengthen ProRata’s new AI-driven search engine, Gist.ai, while showing how content that powers AI-driven searches can be sustainably attributed.
The pilot – ProRata’s first with a scientific publisher – ...
2025-01-29
To store ever more data in electronic devices of the same size, the manufacturing processes for these devices need to be studied in greater detail. By investigating new approaches to making digital memory at the atomic scale, researchers engaged in a public-private partnership are aiming to address the endless demand for denser data storage.
One such effort has focused on developing the ideal manufacturing process for a type of digital memory known as 3D NAND flash memory, which stacks data vertically to increase storage density. The narrow, deep holes required for this type of memory can be etched ...
2025-01-29
DALLAS, Jan. 29, 2025 — The American Heart Association, a global force changing the future of health for all, and the National Football League (NFL), in collaboration with its 32 NFL clubs, are challenging kids to get moving and PLAY 60 in advance of Super Bowl LIX with the latest installment of the NFL PLAY 60 Fitness Break school broadcast series. On Thursday, Feb. 5 at 1 p.m. ET/ 12 p.m. CT/ 10 a.m. PT the Association and the NFL will deliver an action-packed, 15-minute synchronous streaming broadcast to help elementary school students ...
2025-01-29
PULLMAN, Wash. — Wandering salamanders are known for gliding high through the canopies of coastal redwood forests, but how the small amphibians stick their landing and take-off with ease remains something of a mystery.
A new study in the Journal of Morphology reveals the answer may have a lot to do with a surprising mechanism: blood-powered toes. The Washington State University-led research team discovered that wandering salamanders (Aneides vagrans) can rapidly fill, trap, and drain the blood in their toe tips to optimize attachment, detachment and general locomotion through their arboreal environment.
The research not only uncovers a previously ...
2025-01-29
Labor and delivery units that are adequately staffed by nurses have lower cesarean birth rates, according to new research published in the journal Nursing Outlook.
“Our findings highlight how crucial nurse staffing is for optimal maternal outcomes,” said Audrey Lyndon, the Vernice D. Ferguson Professor in Health Equity and executive vice dean at NYU Rory Meyers College of Nursing.
C-sections account for nearly a third of births in the US and are the most common surgery performed in hospitals. While C-sections can be lifesaving and some are necessary for the health of the mother and child, the surgery carries more risks and a longer recovery ...
2025-01-29
Food allergy, or the aggressive immune system reaction following the consumption of a certain food or food ingredient, typically involves immunoglobulin E (IgE) antibodies and can be potentially life-threatening. Often, the immune response to a food protein can be rapid and severe, requiring emergency care. In recent years, scientific studies have revealed that mucosal mast cells (MMCs), which are immune cells that arise from bone marrow, are excessively produced and play a key role in the severity and sudden onset ...
2025-01-29
Melbourne researchers have discovered crucial new information about how microbes consume huge amounts of carbon monoxide (CO) and help reduce levels of this deadly gas.
Over two billion tonnes of carbon monoxide are released into the atmosphere globally each year. Microbes consume about 250 million tonnes of this, reducing CO to safer levels.
The Monash University-led Study, published in Nature Chemical Biology, reveals at an atomic level how microbes consume CO present in the atmosphere. They use a special enzyme, called the CO dehydrogenase, ...
2025-01-29
CLEVELAND, Ohio (Jan 29, 2025)—Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is most likely to suffer with more serious disease symptoms based on leukocyte (white blood cell) count. Results of the study are published online today in Menopause, the journal of The Menopause Society.
Millions of people worldwide suffer from the ongoing effects of COVID-19—which is caused by the SARs-CoV-2 ...
2025-01-29
A recent study involving researchers at Murdoch University’s Health Futures Institute has revealed that moderate-intensity exercise can significantly influence appetite-related hormones and perceptions in males with obesity.
The study, titled “Acute effect of exercise on appetite-related factors in males with obesity,” provides new insights into how exercise can aid appetite control and weight management.
One of the study authors, Associate Professor Timothy Fairchild from Murdoch’s School ...
2025-01-29
Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the available evidence, published in the open access journal Regional Anesthesia & Pain Medicine.
Notwithstanding wide regional variations, platinum based drugs, taxanes, and lung cancer seem to be associated with the highest rates of persistent painful neuropathy, lasting at least 3 months, the findings suggest, prompting the researchers to call for tailored approaches to pain ...
LAST 30 PRESS RELEASES:
[Press-News.org] Pathogenic variants in retinoblastoma suggest a potential gain-of-function mutation
“In other words, the pR552* mutant behaves more like a gain-of-function or oncogenic mutant. Indeed, a family carrying this mutation showed complete penetrance and high expressivity”
